Jove
Visualize
Contact Us

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

318
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
318
Depression: Overview01:18

Depression: Overview

611
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
611
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

640
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
640
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

382
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
382
Long-term Depression01:03

Long-term Depression

2.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.8K
Long-term Depression01:05

Long-term Depression

32.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Prediction of Renal Tumor Malignancy From Radiology Reports and Structured Electronic Health Records: Retrospective Cohort Study.

JMIR medical informatics·2026
Same author

Hematologic biomarkers of aging (HemeAge) and cardiovascular risk: a machine learning analysis in two cohorts.

American journal of preventive cardiology·2026
Same author

Identifying postpartum depression subtypes using natural language processing and clinical notes.

BMJ mental health·2026
Same author

Transportation noise exposure and incident type 2 diabetes: A retrospective cohort study in a large U.S. healthcare system.

Diabetes, obesity & metabolism·2026
Same author

Short-term associations between ambient temperature and incident myocardial infarction: Insights from Houston Methodist cardiovascular learning health system registry.

American journal of preventive cardiology·2026
Same author

Development and Validation of an Electronic Health Record-Based Algorithm for Identifying Patients With Long-Term Opioid Therapy: Cross-Sectional Study.

Journal of medical Internet research·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 5, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.0K

Subphenotyping depression using machine learning and electronic health records.

Zhenxing Xu1, Fei Wang1, Prakash Adekkanattu1

  • 1Weill Cornell Medicine New York New York USA.

Learning Health Systems
|October 21, 2020
PubMed
Summary

Machine learning identified three distinct depression subphenotypes from electronic health records (EHRs). These patient groups differ in age, comorbidities, and medication use, highlighting depression

Keywords:
depressionelectronic health recordsmachine learningphenotyping

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.3K

Related Experiment Videos

Last Updated: Dec 5, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.0K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.3K

Area of Science:

  • Computational psychiatry
  • Machine learning in healthcare
  • Clinical informatics

Background:

  • Depression is a complex disorder with varied presentations.
  • Understanding depression heterogeneity is crucial for effective treatment.
  • Electronic Health Records (EHRs) offer rich data for patient stratification.

Purpose of the Study:

  • To identify distinct depression subphenotypes using machine learning algorithms.
  • To analyze the demographic, comorbidity, and medication profiles of these subphenotypes.
  • To enhance the understanding of depression's heterogeneous nature.

Main Methods:

  • Applied multiple machine learning (ML) algorithms to EHR data.
  • Analyzed a cohort of 11,275 patients diagnosed with depression.
  • Utilized the INSIGHT Clinical Research Network (CRN) database.

Main Results:

  • Identified three depression subphenotypes: Phenotype_A (older, most comorbidities, most medications), Phenotype_B (moderate functional loss, asthma, fibromyalgia, chronic pain/fatigue), and Phenotype_C (younger, fewest comorbidities, fewer medications, anxiety, tobacco use).
  • Phenotype_A comprised 31.35% of patients, Phenotype_B 52.65%, and Phenotype_C 16.31%.
  • Significant differences in age, comorbidity profiles, and medication patterns were observed across the three phenotypes.

Conclusions:

  • Machine learning-derived depression subtypes offer meaningful clinical insights.
  • These findings underscore depression's heterogeneity.
  • Further research is needed to apply these phenotypes in clinical trial design and patient care.